EA202091653A1 - Миноциклин для лечения воспалительных заболеваний кожи - Google Patents

Миноциклин для лечения воспалительных заболеваний кожи

Info

Publication number
EA202091653A1
EA202091653A1 EA202091653A EA202091653A EA202091653A1 EA 202091653 A1 EA202091653 A1 EA 202091653A1 EA 202091653 A EA202091653 A EA 202091653A EA 202091653 A EA202091653 A EA 202091653A EA 202091653 A1 EA202091653 A1 EA 202091653A1
Authority
EA
Eurasian Patent Office
Prior art keywords
minocycline
inflammatory skin
treatment
skin diseases
skin disease
Prior art date
Application number
EA202091653A
Other languages
English (en)
Inventor
Свати Кулкарни
Биджай Кумар Падхи
Шавас Аликунджу
Раджеев Сингх Рагхуванши
Сринивас Рамчандра Сидгидди
Анирудх Гаутам
Original Assignee
Д-Р Редди'С Лабораторис Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Д-Р Редди'С Лабораторис Лтд. filed Critical Д-Р Редди'С Лабораторис Лтд.
Publication of EA202091653A1 publication Critical patent/EA202091653A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящая заявка относится к способу лечения воспалительного заболевания кожи путем применения фармацевтической композиции, содержащей уменьшенную дозу миноциклина, у субъекта, нуждающегося в этом, где указанное применение обеспечивает эффективную концентрацию миноциклина в плазме или интерстициальной жидкости для лечения воспалительного заболевания кожи.
EA202091653A 2018-01-07 2019-01-07 Миноциклин для лечения воспалительных заболеваний кожи EA202091653A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201741023993 2018-01-07
PCT/IB2019/000144 WO2019135166A1 (en) 2018-01-07 2019-01-07 Minocycline for treating inflammatory skin conditions

Publications (1)

Publication Number Publication Date
EA202091653A1 true EA202091653A1 (ru) 2020-12-23

Family

ID=65269058

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202091653A EA202091653A1 (ru) 2018-01-07 2019-01-07 Миноциклин для лечения воспалительных заболеваний кожи

Country Status (11)

Country Link
US (4) US11191740B2 (ru)
EP (1) EP3735249A1 (ru)
JP (1) JP2021509409A (ru)
KR (1) KR20200108018A (ru)
CN (1) CN111818927A (ru)
AU (1) AU2019205134A1 (ru)
BR (1) BR112020013789A2 (ru)
CA (1) CA3087838A1 (ru)
EA (1) EA202091653A1 (ru)
MX (1) MX2020007222A (ru)
WO (1) WO2019135166A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020007222A (es) 2018-01-07 2020-12-10 Dr Reddys Laboratories Ltd Metodos para el tratamiento de afecciones inflamatorias de la piel.
CA3106884A1 (en) * 2018-07-19 2020-01-23 Clark Equipment Company Display position for cab with overhead door

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7211267B2 (en) 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
EP2221056A1 (en) * 2001-04-05 2010-08-25 Collagenex Pharmaceuticals, Inc. Tetracyclines for the treatment of acne
NZ534613A (en) 2002-04-16 2007-07-27 Collagenex Pharm Inc Methods of simultaneously treating ocular rosacea and acne rosacea with a tetracycline compound
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
CA2776471C (en) 2009-10-02 2019-02-12 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US20140186269A1 (en) 2013-01-03 2014-07-03 Foamix Ltd. Vehicle compositions essentially free of pharmaceutically active agents for the improved treatment of acne and related disorders
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
MX2020007222A (es) 2018-01-07 2020-12-10 Dr Reddys Laboratories Ltd Metodos para el tratamiento de afecciones inflamatorias de la piel.

Also Published As

Publication number Publication date
KR20200108018A (ko) 2020-09-16
US20200222345A1 (en) 2020-07-16
JP2021509409A (ja) 2021-03-25
US20210121420A1 (en) 2021-04-29
AU2019205134A1 (en) 2020-08-20
WO2019135166A1 (en) 2019-07-11
US20190209500A1 (en) 2019-07-11
US11191740B2 (en) 2021-12-07
US11364212B2 (en) 2022-06-21
WO2019135166A9 (en) 2020-07-16
BR112020013789A2 (pt) 2021-02-17
US20230131030A1 (en) 2023-04-27
US10905664B2 (en) 2021-02-02
MX2020007222A (es) 2020-12-10
CA3087838A1 (en) 2019-07-11
AU2019205134A2 (en) 2020-08-20
EP3735249A1 (en) 2020-11-11
RU2020125984A3 (ru) 2022-02-07
RU2020125984A (ru) 2022-02-07
CN111818927A (zh) 2020-10-23

Similar Documents

Publication Publication Date Title
EA202090955A1 (ru) Способы применения ингибиторов ehmt2 в лечении или предупреждении нарушений со стороны крови
AR105712A1 (es) Composiciones de insulina de rápida acción
MX2022013172A (es) Uso de un inhibidor de pcsk9 para tratar la hiperlipidemia.
AR101740A1 (es) Terapia de combinación y composiciones
BR112015022197A8 (pt) uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia
MX2019002510A (es) Metodos para usar un anticuerpo biespecifico que reconoce el factor de coagulacion ix y/o el factor de coagulacion ix activado y el factor de coagulacion x y/o factor de coagulacion x activado.
IN2015DN00376A (ru)
EA202192122A1 (ru) Соединения, обладающие активностью индуцирования ферроптоза, и способы их применения
MX2016015437A (es) Combinacion que comprende un glucocorticoide y edo-s101.
CY1122508T1 (el) Παρασκευευασματα για θεραπεια gd2 θετικου καρκινου
MX2022014792A (es) Cocristales, composiciones farmaceuticas de los mismos y metodos de tratamiento que los implican.
JOP20200031A1 (ar) طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة
EA202091653A1 (ru) Миноциклин для лечения воспалительных заболеваний кожи
EA201691656A2 (ru) Терапевтические способы с применением норибогаина и родственных соединений
MX2021007330A (es) Composiciones y métodos terapéuticos para tratar cáncer usando ácido 6, 8-bis-benciltio-octanoico y un inhibidor de autofagia.
AR103118A1 (es) Tratamientos médicos basados en anamorelina
BR112016023011A2 (pt) tratamento de câncer gástrico
EA202193276A1 (ru) Способы лечения холангиокарциномы
EA201500765A1 (ru) Способы лечения сердечно-сосудистых заболеваний
WO2019055776A3 (en) Compositions and methods for treatment of diseases involving cxcl1 function
MX2019004200A (es) Terapia de combinacion.
EA201990550A1 (ru) Офтальмологический препарат, включающий азоловое соединение
EA202091446A1 (ru) Способы лечения хронических воспалительных заболеваний
EA202190294A1 (ru) Комбинированная терапия для лечения рака
AR104172A1 (es) Terapia de combinación con fgfr / pd-1 para el tratamiento del cáncer